Entry - #610678 - COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4 - OMIM
# 610678

COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16p11.2 Combined oxidative phosphorylation deficiency 4 610678 AR 3 TUFM 602389
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Other
- Intrauterine growth retardation
HEAD & NECK
Head
- Microcephaly (patient A)
Eyes
- Nystagmus (patient A)
RESPIRATORY
- Respiratory failure
MUSCLE, SOFT TISSUES
- Hypotonia, neonatal
NEUROLOGIC
Central Nervous System
- Developmental regression
- Encephalopathy (patient A)
- Hypertonia (patient A)
- Spasticity (patient A)
- Cystic leukodystrophy (patient A)
- Micropolygyria (patient A)
- Abnormalities of the basal ganglia on brain imaging
- Leigh syndrome
METABOLIC FEATURES
- Lactic acidosis
LABORATORY ABNORMALITIES
- Increased serum lactate
- Hyperammonemia
MISCELLANEOUS
- Onset in infancy
- Death in infancy may occur
MOLECULAR BASIS
- Caused by mutation in the mitochondrial Tu translation elongation factor gene (TUFM, 602389.0001)
Combined oxidative phosphorylation deficiency - PS609060 - 59 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p34.2 Combined oxidative phosphorylation deficiency 35 AR 3 617873 TRIT1 617840
1q21.2 Combined oxidative phosphorylation deficiency 21 AR 3 615918 TARS2 612805
1q25.1 ?Combined oxidative phosphorylation deficiency 38 AR 3 618378 MRPS14 611978
2p16.1 Combined oxidative phosphorylation deficiency 13 AR 3 614932 PNPT1 610316
2p11.2 Combined oxidative phosphorylation deficiency 51 AR 3 619057 PTCD3 614918
2q33.1 ?Combined oxidative phosphorylation deficiency 25 AR 3 616430 MARS2 609728
2q33.1 Combined oxidative phosphorylation deficiency 53 AR 3 619423 C2orf69 619219
2q33.3 Combined oxidative phosphorylation deficiency 44 AR 3 618855 FASTKD2 612322
2q36.1 Combined oxidative phosphorylation deficiency 16 AR 3 615395 MRPL44 611849
3p25.2 Combined oxidative phosphorylation deficiency 56 3 620139 TAMM41 614948
3p25.1 ?Combined oxidative phosphorylation deficiency 50 AR 3 619025 MRPS25 611987
3p14.1 Combined oxidative phosphorylation deficiency 28 AR 3 616794 SLC25A26 611037
3q11.2 Combined oxidative phosphorylation deficiency 48 AR 3 619012 NSUN3 617491
3q12.3 Combined oxidative phosphorylation deficiency 30 AR 3 616974 TRMT10C 615423
3q22.1 Combined oxidative phosphorylation deficiency 9 AR 3 614582 MRPL3 607118
3q23 Combined oxidative phosphorylation deficiency 5 AR 3 611719 MRPS22 605810
3q25.32 Combined oxidative phosphorylation deficiency 1 AR 3 609060 GFM1 606639
4q31.3 ?Combined oxidative phosphorylation deficiency 41 AR 3 618838 GATB 603645
5q13.3 Combined oxidative phosphorylation deficiency 39 AR 3 618397 GFM2 606544
6p25.1 ?Combined oxidative phosphorylation deficiency 19 AR 3 615595 LYRM4 613311
6p25.1 Combined oxidative phosphorylation deficiency 14 AR 3 614946 FARS2 611592
6p21.33 Combined oxidative phosphorylation deficiency 20 AR 3 615917 VARS2 612802
6p21.1 Combined oxidative phosphorylation deficiency 8 AR 3 614096 AARS2 612035
6q13 Combined oxidative phosphorylation deficiency 10 AR 3 614702 MTO1 614667
6q21 Combined oxidative phosphorylation deficiency 40 AR 3 618835 QRSL1 617209
6q25.1 Combined oxidative phosphorylation deficiency 11 AR 3 614922 RMND1 614917
8q21.13 ?Combined oxidative phosphorylation deficiency 47 AR 3 618958 MRPS28 611990
9q34.3 Combined oxidative phosphorylation deficiency 36 AR 3 617950 MRPS2 611971
10q22.2 Combined oxidative phosphorylation deficiency 2 AR 3 610498 MRPS16 609204
10q26.11 Combined oxidative phosphorylation deficiency 18 AR 3 615578 SFXN4 615564
11q14.1 Combined oxidative phosphorylation deficiency 24 AR 3 616239 NARS2 612803
12q14.1 Combined oxidative phosphorylation deficiency 3 AR 3 610505 TSFM 604723
12q24.31 Combined oxidative phosphorylation deficiency 42 AR 3 618839 GATC 617210
12q24.31 Combined oxidative phosphorylation deficiency 7 AR 3 613559 MTRFR 613541
13q12.12 Combined oxidative phosphorylation deficiency 31 AR 3 617228 MIPEP 602241
13q34 Combined oxidative phosphorylation deficiency 27 AR 3 616672 CARS2 612800
14q13.2 Combined oxidative phosphorylation deficiency 54 AR 3 619737 PRORP 609947
14q23.1 Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay AR 3 616539 TRMT5 611023
15q22.31 Combined oxidative phosphorylation deficiency 15 AR 3 614947 MTFMT 611766
16p13.3 Combined oxidative phosphorylation deficiency 32 AR 3 617664 MRPS34 611994
16p12.2 Combined oxidative phosphorylation deficiency 12 AR 3 614924 EARS2 612799
16p11.2 Combined oxidative phosphorylation deficiency 4 AR 3 610678 TUFM 602389
17p13.3 ?Combined oxidative phosphorylation deficiency 43 AR 3 618851 TIMM22 607251
17p13.2 Combined oxidative phosphorylation deficiency 33 AR 3 617713 C1QBP 601269
17p12 Combined oxidative phosphorylation deficiency 17 AR 3 615440 ELAC2 605367
17p11.2 ?Combined oxidative phosphorylation deficiency 49 AR 3 619024 MEIF2 615498
17q11.2 Combined oxidative phosphorylation deficiency 58 AR 3 620451 TEFM 616422
17q22 ?Combined oxidative phosphorylation deficiency 46 AR 3 618952 MRPS23 611985
17q25.1 ?Combined oxidative phosphorylation deficiency 34 AR 3 617872 MRPS7 611974
17q25.3 ?Combined oxidative phosphorylation deficiency 45 AR 3 618951 MRPL12 602375
18q21.1 ?Combined oxidative phosphorylation deficiency 22 AR 3 616045 ATP5F1A 164360
19p13.3 Combined oxidative phosphorylation deficiency 55 AD, AR 3 619743 POLRMT 601778
19p13.3 Combined oxidative phosphorylation deficiency 37 AR 3 618329 MICOS13 616658
19p13.11 Combined oxidative phosphorylation deficiency 23 AR 3 616198 GTPBP3 608536
20p12.3 Combined oxidative phosphorylation deficiency 57 AR 3 620167 CRLS1 608188
20q11.22 Combined oxidative phosphorylation deficiency 52 AR 3 619386 NFS1 603485
21q21.3 Combined oxidative phosphorylation deficiency 59 AR 3 620646 MRPL39 611845
22q12.3 ?Combined oxidative phosphorylation deficiency 29 AR 3 616811 TXN2 609063
Xq26.1 Combined oxidative phosphorylation deficiency 6 XLR 3 300816 AIFM1 300169

TEXT

A number sign (#) is used with this entry because of evidence that combined oxidative phosphorylation deficiency-4 (COXPD4) is caused by homozygous or compound heterozygous mutation in the gene encoding mitochondrial elongation factor Tu (TUFM; 602389) on chromosome 16p11.

For a discussion of genetic heterogeneity of combined oxidative phosphorylation deficiency, see COXPD1 (609060).


Clinical Features

Valente et al. (2007) described 2 infants with neonatal lactic acidosis, rapidly progressive encephalopathy, severely decreased mitochondrial protein synthesis, and combined deficiency of mtDNA-related mitochondrial respiratory chain (MRC) complexes. One had a mutation in the EFG1 gene (GFM1; 606639) and thus had COXPD1. The other had an extremely severe syndrome dominated by lactic acidosis and rapidly fatal encephalopathy, with diffuse cystic leukodystrophy and micropolygyria, a developmental abnormality of the brain that occurs well before birth. Two days after birth, the infant developed acute respiratory distress and severe metabolic acidosis, with 2 episodes of generalized hypertonia. Serum lactic acid was markedly elevated. Brain CT scan showed several hypodense lesions. The lactic acidosis was partially corrected by intravenously administered bicarbonate. She was relatively well until the age 6 months, when she had another episode of severe metabolic crisis. Thereafter acute episodes punctuated a relentless downhill course characterized by severe psychomotor regression with microcephaly, generalized axial hypotonia with limb spasticity, and nystagmus. Modest elevation of hepatic enzymes in blood and episodic hyperammonemia indicated mild liver involvement that never progressed to hepatic failure. Other tissues, notably the heart, were clinically spared. The patient died at the age of 14 months.

Kohda et al. (2016) reported 2 unrelated infants with COXPD4. Patient 559 had lactic acidosis, hyperammonemia, abnormalities of the basal ganglia on brain imaging, and complex IV deficiency. Patient 622 had intrauterine growth retardation, premature birth, respiratory failure, hypotonia, lactic acidosis, and combined complex deficiencies. Each proband had a similarly affected sib. Additional clinical details were limited.


Inheritance

The transmission pattern of COXPD4 in the families reported by Kohda et al. (2016) was consistent with autosomal recessive inheritance.


Molecular Genetics

In an infant with combined oxidative phosphorylation deficiency, Valente et al. (2007) detected a homozygous missense mutation in the TUFM gene (R339Q; 602389.0001).

In 4 infants from 2 unrelated families with COXPD4, Kohda et al. (2016) identified biallelic mutations in the TUFM gene (602389.0002-602389.0003). The mutations, which were found by high-throughput exome sequencing of 142 unrelated patients with childhood-onset mitochondrial respiratory chain disorders, were confirmed by Sanger sequencing. The mutations segregated with the disorder in the families. Complementation with wildtype TUFM restored the complex I and IV assembly and complex IV activity levels in fibroblasts from 1 of the patients (patient 622).


REFERENCES

  1. Kohda, M., Tokuzawa, Y., Kishita, Y., Nyuzuki, H., Moriyama, Y., Mizuno, Y., Hirata, T., Yatsuka, Y., Yamashita-Sugahara, Y., Nakachi, Y., Kato, H., Okuda, A., and 23 others. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12: e1005679, 2016. Note: Electronic Article. [PubMed: 26741492, images, related citations] [Full Text]

  2. Valente, L., Tiranti, V., Marsano, R. M., Malfatti, E., Fernandez-Vizarra, E., Donnini, C., Mereghetti, P., De Gioia, L., Burlina, A., Castellan, C., Comi, G. P., Savasta, S., Ferrero, I., Zeviani, M. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am. J. Hum. Genet. 80: 44-58, 2007. Note: Erratum: Am. J. Hum. Genet. 80: 580 only, 2007. [PubMed: 17160893, images, related citations] [Full Text]


Contributors:
Cassandra L. Kniffin - updated : 11/30/2016
Creation Date:
Victor A. McKusick : 1/3/2007
carol : 12/02/2016
ckniffin : 11/30/2016
alopez : 08/04/2015
carol : 7/21/2011
carol : 7/21/2011
carol : 3/1/2007
alopez : 1/3/2007

# 610678

COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4


SNOMEDCT: 766876004;   ORPHA: 254925;   DO: 0111494;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16p11.2 Combined oxidative phosphorylation deficiency 4 610678 Autosomal recessive 3 TUFM 602389

TEXT

A number sign (#) is used with this entry because of evidence that combined oxidative phosphorylation deficiency-4 (COXPD4) is caused by homozygous or compound heterozygous mutation in the gene encoding mitochondrial elongation factor Tu (TUFM; 602389) on chromosome 16p11.

For a discussion of genetic heterogeneity of combined oxidative phosphorylation deficiency, see COXPD1 (609060).


Clinical Features

Valente et al. (2007) described 2 infants with neonatal lactic acidosis, rapidly progressive encephalopathy, severely decreased mitochondrial protein synthesis, and combined deficiency of mtDNA-related mitochondrial respiratory chain (MRC) complexes. One had a mutation in the EFG1 gene (GFM1; 606639) and thus had COXPD1. The other had an extremely severe syndrome dominated by lactic acidosis and rapidly fatal encephalopathy, with diffuse cystic leukodystrophy and micropolygyria, a developmental abnormality of the brain that occurs well before birth. Two days after birth, the infant developed acute respiratory distress and severe metabolic acidosis, with 2 episodes of generalized hypertonia. Serum lactic acid was markedly elevated. Brain CT scan showed several hypodense lesions. The lactic acidosis was partially corrected by intravenously administered bicarbonate. She was relatively well until the age 6 months, when she had another episode of severe metabolic crisis. Thereafter acute episodes punctuated a relentless downhill course characterized by severe psychomotor regression with microcephaly, generalized axial hypotonia with limb spasticity, and nystagmus. Modest elevation of hepatic enzymes in blood and episodic hyperammonemia indicated mild liver involvement that never progressed to hepatic failure. Other tissues, notably the heart, were clinically spared. The patient died at the age of 14 months.

Kohda et al. (2016) reported 2 unrelated infants with COXPD4. Patient 559 had lactic acidosis, hyperammonemia, abnormalities of the basal ganglia on brain imaging, and complex IV deficiency. Patient 622 had intrauterine growth retardation, premature birth, respiratory failure, hypotonia, lactic acidosis, and combined complex deficiencies. Each proband had a similarly affected sib. Additional clinical details were limited.


Inheritance

The transmission pattern of COXPD4 in the families reported by Kohda et al. (2016) was consistent with autosomal recessive inheritance.


Molecular Genetics

In an infant with combined oxidative phosphorylation deficiency, Valente et al. (2007) detected a homozygous missense mutation in the TUFM gene (R339Q; 602389.0001).

In 4 infants from 2 unrelated families with COXPD4, Kohda et al. (2016) identified biallelic mutations in the TUFM gene (602389.0002-602389.0003). The mutations, which were found by high-throughput exome sequencing of 142 unrelated patients with childhood-onset mitochondrial respiratory chain disorders, were confirmed by Sanger sequencing. The mutations segregated with the disorder in the families. Complementation with wildtype TUFM restored the complex I and IV assembly and complex IV activity levels in fibroblasts from 1 of the patients (patient 622).


REFERENCES

  1. Kohda, M., Tokuzawa, Y., Kishita, Y., Nyuzuki, H., Moriyama, Y., Mizuno, Y., Hirata, T., Yatsuka, Y., Yamashita-Sugahara, Y., Nakachi, Y., Kato, H., Okuda, A., and 23 others. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 12: e1005679, 2016. Note: Electronic Article. [PubMed: 26741492] [Full Text: https://doi.org/10.1371/journal.pgen.1005679]

  2. Valente, L., Tiranti, V., Marsano, R. M., Malfatti, E., Fernandez-Vizarra, E., Donnini, C., Mereghetti, P., De Gioia, L., Burlina, A., Castellan, C., Comi, G. P., Savasta, S., Ferrero, I., Zeviani, M. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am. J. Hum. Genet. 80: 44-58, 2007. Note: Erratum: Am. J. Hum. Genet. 80: 580 only, 2007. [PubMed: 17160893] [Full Text: https://doi.org/10.1086/510559]


Contributors:
Cassandra L. Kniffin - updated : 11/30/2016

Creation Date:
Victor A. McKusick : 1/3/2007

Edit History:
carol : 12/02/2016
ckniffin : 11/30/2016
alopez : 08/04/2015
carol : 7/21/2011
carol : 7/21/2011
carol : 3/1/2007
alopez : 1/3/2007